???pagination.result.count???
???pagination.result.page???
1
Molecular determinants of multiple effects of nickel on NMDA receptor channels. , Gavazzo P., Neurotox Res. January 1, 2009; 15 (1): 38-48.
Enantiomeric propanolamines as selective N-methyl-D-aspartate 2B receptor antagonists. , Tahirovic YA., J Med Chem. September 25, 2008; 51 (18): 5506-21.
Cyclophane and acyclic cyclophane: novel channel blockers of N-methyl-D-aspartate receptor. , Masuko T., Neurochem Int. January 1, 2007; 50 (2): 443-9.
Characterization of two novel N-methyl-D-aspartate antagonists: EAA-090 (2-[8,9-dioxo-2,6-diazabicyclo [5.2.0]non-1(7)- en2-yl]ethylphosphonic acid) and EAB-318 (R-alpha-amino-5-chloro-1-(phosphonomethyl)-1H-benzimidazole-2-propanoic acid hydrochloride). , Sun L., J Pharmacol Exp Ther. August 1, 2004; 310 (2): 563-70.
Anthraquinone polyamines: novel channel blockers to study N-methyl-D-aspartate receptors. , Kashiwagi K ., J Pharmacol Exp Ther. June 1, 2004; 309 (3): 884-93.
Pharmacology of delta2 glutamate receptors: effects of pentamidine and protons. , Williams K., J Pharmacol Exp Ther. May 1, 2003; 305 (2): 740-8.
Pharmacological characterization of Ro 63-1908 (1-[2-(4-hydroxy-phenoxy)-ethyl]-4-(4-methyl-benzyl)-piperidin-4-ol), a novel subtype-selective N-methyl-D-aspartate antagonist. , Gill R., J Pharmacol Exp Ther. September 1, 2002; 302 (3): 940-8.
Conantokin G is an NR2B-selective competitive antagonist of N-methyl-D-aspartate receptors. , Donevan SD., Mol Pharmacol. September 1, 2000; 58 (3): 614-23.
In vitro and in vivo characterization of conantokin-R, a selective NMDA receptor antagonist isolated from the venom of the fish-hunting snail Conus radiatus. , White HS., J Pharmacol Exp Ther. January 1, 2000; 292 (1): 425-32.
Structure-activity relationship of N-(phenylalkyl)cinnamides as novel NR2B subtype-selective NMDA receptor antagonists. , Tamiz AP., J Med Chem. August 26, 1999; 42 (17): 3412-20.